Antimicrobial stewardship interventions in the emergency department
Citation: Losier M, Ramsey TD, Wilby KJ, et al. A systematic review of antimicrobial stewardship interventions in the emergency department. Annals of Pharmacotherapy 2017; 51(9): 774-90
Free to view: No
What is this? The COVID-19 pandemic is placing a great strain on health systems and healthcare workers. Existing research on the use of antimicrobial stewardship programmes to improve the use of antimicrobials in emergency departments may provide information on strategies to help.
In this systematic review, the authors searched for research characterizing the use of antimicrobial stewardship programmes in emergency departments and evaluating related interventions that might improve patient care or health outcomes. They did not restrict by type of publication but restricted their searches to articles published in English before November 2016. They included 43 studies, 36 of which used an uncontrolled before-and-after design.
What was found: Most studies had unclear or high risk of bias.
Patient or provider education and guideline or clinical pathway implementation were the most frequently reported interventions.
The impact of interventions showed variable results but some benefits of antimicrobial stewardship programmes may include improvement in delivery of care, a decrease in antimicrobial use, and better adherence to guidelines.
What’s uncertain: Although antimicrobial stewardship programmes in emergency departments may improve patient care, the optimal intervention or combination of interventions is uncertain.
There were few studies of audit and feedback as an antimicrobial stewardship intervention in emergency departments, so the effects of this intervention are uncertain.
No study evaluated preauthorization of antimicrobial use in emergency departments, so the effects of this intervention are uncertain.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.